IP
Healthcare & Life Sciences
Impel Pharmaceuticals
United Statesimpelpharma.com
Impel Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Impel Pharmaceuticals
Based in the United States, Impel Pharmaceuticals is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Impel Pharmaceuticals develops and provides therapies using proprietary Precision Olfactory Delivery technology to optimize drug delivery to the upper nasal space, including the approved migraine treatment Trudhesa nasal spray.
Explore Impel Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.